LDHA induces beta cell dedifferentiation in diabetes through metabolic and epigenetic reprogramming

Xirui Li1,2, Haoqiang Gong2, Can Xiong2

  • 1Department of Cardiovascular Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.

Diabetologia
|December 11, 2025
PubMed
Abstract

Insights

Lactate dehydrogenase A (LDHA) inhibition preserves pancreatic beta cell identity and function, offering a potential new treatment for diabetes. This study reveals LDHA

Area of Science:

  • Metabolic and Epigenetic Regulation in Diabetes
  • Pancreatic Beta Cell Biology
  • Molecular Mechanisms of Diabetes

Background:

  • Pancreatic beta cell dedifferentiation is a key factor in diabetes, reducing beta cell mass and function.
  • Understanding the molecular mechanisms of beta cell dedifferentiation is crucial for developing effective diabetes treatments.
  • Interventional targets are needed to prevent or reverse beta cell dedifferentiation.

Purpose of the Study:

  • To investigate the role of Lactate dehydrogenase A (LDHA) in pancreatic beta cell dedifferentiation.
  • To explore LDHA inhibition as a potential therapeutic strategy for diabetes.
  • To elucidate the molecular mechanisms linking LDHA, epigenetic modifications, and beta cell dysfunction.

Main Methods:

  • Analysis of LDHA expression and activity in human diabetic islets and mouse models (db/db and HFD-induced).
  • Assessment of LDHA inhibition effects on beta cell function and identity in diabetic mice.
  • Chromatin immunoprecipitation sequencing (ChIP-seq) and RNA sequencing (RNA-seq) to study LDHA's impact on histone lactylation and gene expression.

Main Results:

  • LDHA inhibition preserved beta cell identity, delayed disease progression in impaired fasting glucose, and improved glucose homeostasis in diabetic models.
  • LDHA activation increased histone H3 lysine 9 lactylation (H3K9la) at key beta cell dedifferentiation marker genes (Sox9, Hes1, Aldh1a3).
  • Increased H3K9la facilitated transcription of dedifferentiation markers, leading to impaired beta cell function and glucose homeostasis.

Conclusions:

  • LDHA plays a critical role in metabolic and epigenetic reprogramming driving beta cell dedifferentiation in diabetes.
  • LDHA-mediated histone lactylation is a key mechanism linking metabolic changes to beta cell dysfunction.
  • Inhibition of LDHA represents a promising novel therapeutic strategy for managing and treating diabetes.

Related Concept Videos

Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
2.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
2.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.2K
Feedback Loops01:01

Feedback Loops

In most cases, excessive hormone production is prevented by negative feedback—a loop that starts with a stimulus inducing the release of a particular substance, like a hormone, to maintain a certain level before triggering a signal that results in a decrease in further release of the hormone.
63.5K